Nanoparticle drug delivery systems for synergistic delivery of tumor therapy

Nanoparticle drug delivery systems have proved anti-tumor effects; however, they are not widely used in tumor therapy due to insufficient ability to target specific sites, multidrug resistance to anti-tumor drugs, and the high toxicity of the drugs. With the development of RNAi technology, nucleic a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Daoyuan, Liu, Xuecun, Lu, Xiaoyan, Tian, Jingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978018/
https://www.ncbi.nlm.nih.gov/pubmed/36874010
http://dx.doi.org/10.3389/fphar.2023.1111991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978018/
https://www.ncbi.nlm.nih.gov/pubmed/36874010
http://dx.doi.org/10.3389/fphar.2023.1111991

Ejemplares similares